SEQUENCE LISTING < 110 > Affimed GmbH < 120 > Combination of an anti - CD 16 A antibody with a cytokine < 130 > A 3316 PCT < 160 > 10 < 170 > PatentIn version 3 . 5 < 210 > 1 < 211 > 8 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > CDR < 400 > 1 Gly Tyr Thr Phe Thr Ser Tyr Tyr 1 5 < 210 > 2 < 211 > 8 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > CDR < 400 > 2 Ile Glu Pro Met Tyr Gly Ser Thr 1 5 < 210 > 3 < 211 > 13 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > CDR < 400 > 3 Ala Arg Gly Ser Ala Tyr Tyr Tyr Asp Phe Ala Asp Tyr 1 5 10 < 210 > 4 < 211 > 6 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > CDR < 400 > 4 Asn Ile Gly Ser Lys Asn 1 5 < 210 > 5 < 211 > 4 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > cdr < 400 > 5 Gln Asp Asn Lys 1 < 210 > 6 < 211 > 9 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > CDR < 400 > 6 Gln Val Trp Asp Asn Tyr Ser Val Leu 1 5 < 210 > 7 < 211 > 8 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > CDR < 400 > 7 Ile Asn Pro Ser Gly Gly Ser Thr 1 5 < 210 > 8 < 211 > 120 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > vh < 400 > 8 Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 1 5 10 15 Ser Leu Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 20 25 30 Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 35 40 45 Gly Ala Ile Glu Pro Met Tyr Gly Ser Thr Ser Tyr Ala Gln Lys Phe 50 55 60 Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 65 70 75 80 Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 85 90 95 Ala Arg Gly Ser Ala Tyr Tyr Tyr Asp Phe Ala Asp Tyr Trp Gly Gln 100 105 110 Gly Thr Leu Val Thr Val Ser Ser 115 120 < 210 > 9 < 211 > 106 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > vl < 400 > 9 Ser Tyr Val Leu Thr Gln Pro Ser Ser Val Ser Val Ala Pro Gly Gln 1 5 10 15 Thr Ala Thr Ile Ser Cys Gly Gly His Asn Ile Gly Ser Lys Asn Val 20 25 30 His Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 35 40 45 Gln Asp Asn Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 50 55 60 Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 65 70 75 80 Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Asn Tyr Ser Val Leu 85 90 95 Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 100 105 < 210 > 10 < 211 > 120 < 212 > PRT < 213 > artificial sequence < 220 > < 223 > vh < 400 > 10 Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 1 5 10 15 Ser Leu Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 20 25 30 Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 35 40 45 Gly Ile Ile Asn Pro Ser Gly Gly Ser Thr Ser Tyr Ala Gln Lys Phe 50 55 60 Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Val Tyr 65 70 75 80 Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 85 90 95 Ala Arg Gly Ser Ala Tyr Tyr Tyr Asp Phe Ala Asp Tyr Trp Gly Gln 100 105 110 Gly Thr Leu Val Thr Val Ser Ser 115 120